MPG.eBooks - Search Results

1

Comparative value of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) testing in combination versus individually for the diagnosis of undifferentiated patients wit...

by Assasi, Nazila
Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...C-Reactive Protein / immunology...”

Read Now

2

Seasonal influenza immunization of health care workers for the prevention of influenza in patients : a review of the clinical effectiveness

by Seal, Kelsey, Spry, Carolyn
Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Influenza Vaccines / immunology...”

Read Now

3

Seasonal influenza immunization of health care workers for the prevention of influenza in patients : a review of the clinical effectiveness

by Seal, Kelsey, Spry, Carolyn
Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Influenza Vaccines / immunology...”

Read Now

4

Prophylactic treatment for contacts of patients with invasive meningococcal disease on sports teams : a review of the clinical effectiveness, cost-effectiveness, and guidelines

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Meningococcal Infections / immunology...”

Read Now

5

Streptococcal antigen test for pneumonia detection : a review of clinical and cost-effectiveness and guidelines

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Streptococcus pneumoniae / immunology...”

Read Now

6

Standardized allergenic extract, timothy grass (phleum pratense) (GRASTEK) (sublingual tablet 2,800 BAU)

Published 2014

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Phleum / immunology...”

Read Now

7

The use of antivirals for influenza prophylaxis : a review of the clinical effectiveness

by Chao, Yi-Sheng, Spry, Carolyn
Published 2017

CADTH

Subjects: “...Influenza, Human / immunology...”

Read Now

8

Clinical review report: Belimumab (Benlysta) (GlaxoSmithKline Inc.) : indication : indicated in addition to standard therapy for reducing disease activity in adult patients with ac...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Lupus Erythematosus, Systemic / immunology...”

Read Now

9

Second-line therapy for patients with relapsing-remitting multiple sclerosis : a review of guidelines

by Li, Ke Xin, Picheca, Lory
Published 2019

CADTH

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

10

Recommendations for drug therapies for relapsing-emitting multiple sclerosis

Published 2013

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

11

Clinical review report: Dupilumab (Dupixent) (Sanofi genzyme, a division of Sanofi-Aventis Canada Inc.) : indication : indicated for the treatment of patients aged 12 years and old...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Immunologic Factors / adverse effects...”

Read Now

12

Immune checkpoint inhibitors for classical Hodgkin lymphoma in brentuximab vedotin-naïve patients : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Williams, D., Gray, Casey, Picheca, Lory
Published 2019

CADTH

Subjects: “...Hodgkin Disease / immunology...”

Read Now

13

Comparative clinical and cost-effectiveness of drug therapies for relapsing-remitting multiple sclerosis : project protocol

Published 2012

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

14

Pharmacoeconomic review report: Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Immunologic Factors / economics...”

Read Now

15

Biologics versus immunomodulators or antibiotics for the management of fistulizing Crohn's disease : a review of comparative clinical effectiveness and cost-effectiveness

by Young, Calvin, Campbell, Kaitryn
Published 2019

CADTH

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

16

Biologics versus immunomodulators or antibiotics for the management of fistulizing Crohn's disease : a review of comparative clinical effectiveness and cost-effectiveness

by Young, Calvin, Campbell, Kaitryn
Published 2019

CADTH

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

17

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

18

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Immunologic Factors / therapeutic use...”

Read Now

19

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus-Hoffmann-La Roche Limited) : indication : management of adult patients with early primary progressive mult...

Published 2018

CADTH

Subjects: “...Immunologic Factors / economics...”

Narrow Search